Update index.md

docs/index.md

@@ -25,18 +25,19 @@ We are developing a novel approach that exploits the ability of the UPS to more
 6. Further work towards clinical use of the evolved E3 ligase for Targeted Protein Degradation.
 
 ## Key achievements:
-- We have identified promising E3 ligases and targets.
-- We developed an evolutionary logic to evolve these E3 ligases. 
-- We showed that phage propagation depends on the substrate used and the presence of both RNAP subunits.
-- We observed a high background propagation in our system, and we developed possible solutions for the observed background phage propagation.
-- We successfully drifted SIAH1. 
+
+* We have identified promising E3 ligases and targets.
+* We developed an evolutionary logic to evolve these E3 ligases.
+* We showed that phage propagation depends on the substrate used and the presence of both RNAP subunits.
+* We observed a high background propagation in our system, and we developed possible solutions for the observed background phage propagation.
+* We successfully drifted SIAH1. 
 
 We also: 
-- We learned the PACE workflow and practiced setting up and running the PACE reactor. 
+* We learned the PACE workflow and practiced setting up and running the PACE reactor. 
 
 We are currently still working on: 
-- Achieving E3 ligase activity-dependent phage propagation in the selection system.
-- Running PANCE and/or PACE to evolve SIAH1/2 towards the recognition of NLRP3. 
+* Achieving E3 ligase activity-dependent phage propagation in the selection system.
+* Running PANCE and/or PACE to evolve SIAH1/2 towards the recognition of NLRP3. 
 
 ## References
 [^ubi_first]:Tsai JM, Nowak RP, Ebert BL, Fischer ES. Targeted protein degradation: from mechanisms to clinic. Nat Rev Mol Cell Biol. 2024;25: 740–757. doi:10.1038/s41580-024-00729-9